An independent ecosystem briefing built by Bracken, supporting SNMMI 2026.The Bracken Group
← All speakers
moderator

Sarah A. Frye

PhD MBA CNMT CCRP FSNMMI-TS (Moderator)

Speaking at SNMMI 2026moderator
Session

SNMMI-TS Plenary Session — Beyond the Bot

Abstract placeholder. Drop in the official SNMMI session abstract once published.

Day and time to be confirmed against the SNMMI program.

Smart questions to ask

If you get five minutes with the speaker

  1. Which trial readout in 2026 will most reshape the field?
  2. What's the most overlooked piece of infrastructure in this ecosystem?
  3. Where do you see PSMA-targeted therapy hitting its real ceiling, clinical or operational?

Generated by a mock model. Wired to Anthropic when the API key is in place.

Recent activity

What we're seeing

  • Endpoints News · 2026-04-05
    Sarah A Frye joins editorial board of European Journal of Nuclear Medicine
    The announcement comes amid tightening Mo-99 and Lu-177 supply.
  • Reuters Health · 2026-03-14
    Sarah A Frye cited in NEJM perspective on theranostic standardization
    The work builds on more than a decade of radiochemistry collaboration.
  • BioPharma Reporter · 2026-02-27
    Sarah A Frye co-authors review on PSMA in Journal of Nuclear Medicine
    Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

Meet Bracken at SNMMI